Hasnyálmirigyrák: vizsgálatok itt: Olaszország
93 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Ancona, Florence, Foggia, Milan
- Életkor
- 18 év and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00 - 1/2. fázisNot yet taking people in OlaszországSNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
- Where
- Modena
- Életkor
- 18 év and over
- People
- 18
- Run by
- Eir Biotherapies S.r.l.
See details and how to join2026-525714-59-00 - 1/2. fázisNot yet taking people in OlaszországPhase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
- Where
- Ancona, Milan, Naples, Padova, Pisa, Reggio Emilia, Rome
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- Merck Healthcare KGaA
See details and how to join2024-517819-74-00 - 3. fázisTaking peoplePhase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
- Where
- Bologna, Florence, Milan, Naples, Padova, Pisa, Rome, Verona
- Életkor
- 18 év and over
- People
- 281 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524928-21-00 - 3. fázisTaking peopleA Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Where
- Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Rome, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Incyte Corp.
See details and how to join2025-525009-18-00 - No phaseTaking peopleRadiology Registry on Pancreatic Malignancies
- Where
- Milan
- Életkor
- 18 év and over
- People
- 1300
- Run by
- IRCCS San Raffaele
See details and how to joinNCT05714111 - 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Ancona, Aviano, Meldola, Milan, Naples, Orbassano, Ravenna, Verona
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 4. fázisTaking peopleEfficacy of PERT for PEI in Unresectable Pancreatic Cancer.
- Where
- Milan
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Hospital Clinico Universitario de Santiago
See details and how to joinNCT06099119 - 4. fázisVisszavonvaPreventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
- Where
- Milan, Padova, Verona
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Amsterdam UMC Stichting
See details and how to join2024-519667-18-00 - No phaseNot yet taking people in OlaszországPersonalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma
- Where
- Padova
- Életkor
- 65 év and over
- People
- 250 worldwide
- Run by
- Inna Chen, MD
See details and how to joinNCT07821554 - 2. fázisTaking people[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Bergamo, Milan, Monza, Rome
- Életkor
- 18 év to 79 év
- People
- 71 worldwide
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07702292 · EU 2025-521983-36-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Meldola, Reggio Emilia, Roma
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 1. fázisTaking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Milan, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - 4. fázisTaking peopleRemimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.
- Where
- Milan
- Életkor
- 18 év and over
- People
- 332
- Run by
- Ospedale San Raffaele S.r.l.
See details and how to join2025-521784-12-00 - 3. fázisTaking peopleGemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
- Where
- Aviano, Bari, Brescia, Crema (CR), Cremona, Florence, Genoa, Meldola, Milan, Misterbianco, Naples, Novara, Padova, Parma, Pavia, Pesaro, Pisa, Ponderano, Prato, Ravenna, Rome, Rozzano, Tricase, Udine
- Életkor
- 18 év and over
- People
- 340
- Run by
- Gruppo Oncologico del Nord-Ovest
See details and how to joinNCT06897644 · EU 2024-515214-41-00 - No phaseTaking peopleIconographic Registry of Pancreatobiliary Endoscopy Procedures
- Where
- Milan
- Életkor
- 18 év and over
- People
- 12 000
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06344507 - 1/2. fázisTaking peoplePhase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma
- Where
- Modena
- Életkor
- 18 év and over
- People
- 9
- Run by
- EIR Biotherapies s.r.l.
See details and how to joinNCT06861452 · EU 2024-516019-26-00 - No phaseNot yet taking people in OlaszországEUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer
- Where
- Milan
- Életkor
- 18 év and over
- People
- 700
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07803770 - 2. fázisNot yet taking people in OlaszországImmune dynamics and biomarkers of anti-tumor response in BMS-986340 (anti-CCR8) and nivolumab (anti-PD-1) co-treatment of metastatic tumors
- Where
- Rozzano
- Életkor
- 18 év and over
- People
- 30
- Run by
- Humanitas Mirasole S.p.A.
See details and how to join2025-524125-40-01 - No phaseNot yet taking people in OlaszországEndoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
- Where
- Bergamo, Brescia, Cremona, Legnano, Mantua, Milan, Monza, Pavia, Varese
- Életkor
- 18 év and over
- People
- 2500
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07418164 - No phaseTaking peopleClinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients
- Where
- Rome
- Életkor
- 18 év and over
- People
- 579
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07608055 - 2. fázisNot yet taking people in OlaszországLuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor
- Where
- Meldola, Milan, Naples, Negrar, Reggio Emilia
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04939610 · EU 2023-508995-12-01 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Milan, Pisa, Verona
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Milan, Reggio Emilia
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192